Healthcare

By

Bruce Kamich

 | Feb 4, 2016 | 12:33 PM EST

Assuming CI closes below $127, the next chart support is not until the $105 area.

By

James Passeri

 | Feb 2, 2016 | 1:55 PM EST

Since the Caribbean biopharm launched its IPO last June, half its market cap seems to have vanished somewhere in the Bermuda Triangle.

By

Bret Jensen

 | Feb 2, 2016 | 9:00 AM EST

In a year's time, investors may look back and think this was a great entry point.

By

Bruce Kamich

 | Feb 1, 2016 | 4:28 PM EST

The chart indicates that the next area of support is around the $80 level.

By

Jared Woodard

 | Feb 1, 2016 | 2:45 PM EST

Owning GSK May calls may give a nice payout on any good news regarding a Zika virus vaccine.

By

Jeremy LaKosh

 | Feb 1, 2016 | 2:00 PM EST

Don't be surprised if Anthem's threat to take its business elsewhere results in a compromise.

By

Timothy Collins

 | Feb 1, 2016 | 11:30 AM EST

This play is a way to buy shares with a $28 average or profit if the stock dips post-earnings.

By

Bruce Kamich

 | Jan 29, 2016 | 4:58 PM EST

At the end of 2015, BMY looked attractive, but starting 2016, shares turned south along with the overall market. 

By

Bruce Kamich

 | Jan 29, 2016 | 3:25 PM EST

The biopharmaceutical company is in for a deeper bear phase. 

By

Bruce Kamich

 | Jan 29, 2016 | 1:17 PM EST

It appears that Amgen's share price erosion may continue given its performance in recent weeks. 

Should read... The U.S. dollar continued to experience WEAKNESS

Reasons to trail down stops on shorts in the indices and also to consider longs if the buy...

JPMorgan Chase's CEO Jamie Dimon buys 500K shares of the company - CNBC, citing DJ

Bunge (BG) reported so-so earnings today while warning the new year is starting off dully....

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.